• 제목/요약/키워드: Chinese drug

검색결과 386건 처리시간 0.025초

Molecular phylogenetic studies on clinical bovine piroplasmosis caused by benign Theileria in Shaanxi Province, China

  • Wang, Jing;Zhang, Jiyu;Zhu, Zhen;Zhou, Xuzheng;Li, Bing
    • Journal of Veterinary Science
    • /
    • 제19권6호
    • /
    • pp.846-849
    • /
    • 2018
  • A group of benign Theileria species, which are often referred to as T. orientalis/T. buffeli/T. sergenti group, has low pathogenicity in cattle. Herein, we report on Theileria spp. in cattle on a farm from China. Based on phylogenetic analysis of the major piroplasm surface protein gene sequences, we detected 6 genotypes that were categorized as Types 1, 2, 3, 4, and 5 as well as an additional Type 9 genotype. The new epidemiological features of the T. orientalis/T. buffeli/T. sergenti parasites in China indicate a greater diversity in the genetics of these species than had been previously thought.

Biotransformation, a Promising Technology for Anti-cancer Drug Development

  • Gao, Fei;Zhang, Jin-Ming;Wang, Zhan-Guo;Peng, Wei;Hu, Hui-Ling;Fu, Chao-Mei
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권10호
    • /
    • pp.5599-5608
    • /
    • 2013
  • With the high morbidity and mortality caused by cancer, finding new and more effective anti-cancer drugs is very urgent. In current research, biotransformation plays a vital role in the research and development of cancer drugs and has obtained some achievements. In this review, we have summarized four applications as follows: to exploit novel anti-cancer drugs, to improve existing anti-cancer drugs, to broaden limited anti-cancer drug resources and to investigate correlative mechanisms. Three different groups of important anti-cancer compounds were assessed to clarify the current practical applications of biotransformation in the development of anti-cancer drugs.

중약주사제 부작용 발생에 관한 분석 연구 (An Analytic Study on the Occurrence of Adverse Drug Reactions of Traditional Chinese Medicine Injections)

  • 황지혜;송호섭
    • 동의생리병리학회지
    • /
    • 제35권6호
    • /
    • pp.219-227
    • /
    • 2021
  • The purpose of this study is to analyze the side effects (ADR) of Traditional Chinese Medicine (TCM) injections by age, injection type, symptoms, and causes, and to find preventive solutions for ADR. For the ADR of TCM injection data collected during the search period from January 1, 2010 to December 31, 2020, the correlation between each section was analyzed by subdividing it into age, injection type, symptoms and causes. CNKI, PubMed, and EMBASE were used to collect the clinical data. 'Chinese herbal injection', 'Traditional Chinese Medicine injection', 'Chinese herbal injection side effect', 'Chinese herbal injection adverse drug reaction' were used for the keyword from the database. All data were collected mainly for TCM injection and the causes of ADR due to TCM injection. However, data not related to the relevant study or TCM injection were excluded from this study. Among a total of 941 studies collected during the search period from January 1, 2010 to December 31, 2020, a total of 10 studies were selected for final analysis. In 1462 clinical data sets, ADR by gender was higher in males than females. By age, 41 to 60 years were the most common. The incidence of ADR by injection type was highest in the blood regulating injection type. Data analysis showed Xueshuantong injection had the highest ADR. Among the symptoms of ADR, skin diseases were the most common. The most common cause of ADR was the unreasonable use of drugs. In China, for ADR management, the use of TCM injections is recommended according to the basic principles for the clinical use of TCM injections established by the Chinese government. In this study, we analyzed the current status and causes of ADR in TCM injections, and found a preventive solution. It is expected that it can be used as basic data to increase the usability of pharmacopuncture and herbal medicines in Korea in the future.

한(韓) 중(中) 일(日)의 공정서(公定書)(약전(藥典) 및 규격집(規格集))에 수재(收載)된 전통천연약물(傳統天然藥物)의 품질(品質)에 관한 조사(調査)(II) -대한약전(大韓藥典) 및 대한약전외(大韓藥典外) 한약(韓藥)(생약)(生藥) 규격집(規格集)의 확인시험법(確認試驗法)에 대한 검토(檢討)- (Examination of the Chemical Tests for Herbal Medicines Listed in the Official Drug Compendia(Pharmacopoeia and Natural Drug Standards) of Korea)

  • 박상희;염정록;장일무
    • 생약학회지
    • /
    • 제22권2호
    • /
    • pp.124-127
    • /
    • 1991
  • In the preceding paper, it was reported that total 63 traditional Korean herbal medicines listed in the Korean Pharmacopoeia and Korean Natural Drug Standards were found to be different plants in terms of systematic botany when those were compared with other two countries' drug compendia, Chinese Pharmacopoeia, Japanese Pharmacopoeia and Japanese Natural Drug Standards. Among 63 traditional Korean herbal drugs, 28 items were subject to the chemical identification test by using official methods that are described in the Korean Pharmacopoeia and the Korean Natural Drug Standards. In addition, 5 items were also tested by using the official methods described in Chinese and Japanese drug compendia, since there are no official chemical tests available in the Korean drug compendia. It was found that most of chemical tests appeared to be suitable. It was noted that the chemical test for Atractylodis Rhizoma(蒼朮) was incorrect and unapplicable. Those chemical tests for Clematidis Radix(威靈仙), Rubi Fructus(覆盆子) and Viticis Fructus(蔓荊子) are desirable to be revised for more accurate identification.

  • PDF

Basic Research Related to the Development of New Traditional Chinese Drugs

  • Guo, De-An
    • 한국응용약물학회:학술대회논문집
    • /
    • 한국응용약물학회 1998년도 Proceedings of UNESCO-internetwork Cooperative Regional Seminar and Workshop on Bioassay Guided Isolation of Bioactive Substances from Natural Products and Microbial Products
    • /
    • pp.114-117
    • /
    • 1998
  • Chinese traditional drugs have a long history to be used in clinics to treat various diseases and are confirmed to be effective approach through thousands of years of medical practice. Therefore, as a common understanding, the drug development from traditional Chinese medicines could be considered as a “shortcut” way with less blindness and more saving of time and money since development of new Chinese drugs has a different approach from that of western new drugs. Firstly, Chinese new drug development can be simplified as “from men to animal” process rather than “from animal to men” in western medicines. Hence the successful rate would be higher. Secondly, the original drugs or prescriptions from which the new drugs are planned to develop have been known what symptoms they are indicated for. Therefore, the developing procedure is actually a refine process with much less blindness than that of western drugs.

  • PDF

중국 약용식물 추출물의 알도즈 환원 효소 억제 효능 검색(X) (Screening of Chinese Herbal Medicines with Inhibitory Effect on Aldose Reductase (X))

  • 최소진;김영숙;김주환;김진숙
    • 생약학회지
    • /
    • 제45권4호
    • /
    • pp.359-365
    • /
    • 2014
  • Aldose reductase (AR) is the key enzyme of the polyol pathway in the development of the diabetic complications. Sixty seven Chinese herbal medicines have been investigated for inhibitory activities on AR. Among them, 7 herbal medicines, Buddleja crispa (twigs and leaves), Taiwania flousiana (twigs and leaves), Sloanea hemsleyana (fruits), Euphorbia nemetocypha (whole plants), Photinia glomerata (twigs and leaves), Vitex yunnanensis (twigs and leaves) exhibited a significant inhibitory activity against AR. Particularly, S. hemsleyana and V. yunnanensis showed 1.2-4.5 times more potent inhibitory activity than the positive control, 3,3-tetramethyleneglutaric acid (TMG).

한약 "용담(龍膽)"의 생약학적 연구 (Pharmacognostical Studies on the Chinese Crude Drug 'Yong Dam')

  • 황명석;박종희
    • 생약학회지
    • /
    • 제32권1호통권124호
    • /
    • pp.1-5
    • /
    • 2001
  • The Chinese crude drug, 'Yong Dam (龍膽)' which is derived from the root of Gentiana plants of the family Gentianaceae, has been used as remedy for stomachic, intestinal catarrh, convulsion, etc. With regard to the botanical origin of 'Yong Dam', it has been considered to be Gentiana species of Gentianaceae, especially Gentiana scabra, but there has no pharmacognostical confirmation on it. To clarify the botanical origin of 'Yong Dam' from Korea, we studied on the anatomical characteristics of Gentiana species growing wild in Korea i.e. Gentiana scabra var. buergeri, G. uchiyamai, G. triflora, G. axillariflora var. coreana and of 'Yong Dam' from Korea on Korean market. Through our studies, the botanical origin of 'Yong Dam' from Korea was proved to be Gentiana scabra var. buergeri and Gentiana axillariflora var. coreana.

  • PDF

생위단의 현미경 감정연구 (Microscopic Identification of the Chinese Patent Medicine Sengwe Dan)

  • 박종희;장경환
    • 생약학회지
    • /
    • 제22권2호
    • /
    • pp.128-133
    • /
    • 1991
  • Sengwe Dan(生胃丹) is a Chinese patent medicine, which is used for stomachic disorder, heavy drinking, voracious eating, acute and chronic indigestion, diarrhea, nausea and vomiting in Korea. In the future, the demand for the drug is likely to increase, as the number of aged people increases. This medicine is in the large of pills consisting 19 kinds of powdered crude drugs. For the identification of individual ingredients in such powdery mixtures, microscopic method may advantageously be used as it requires only a small amount of specimens. In this paper, the effectiveness of this method is exemplified by the identification of the ingredients in Seng-We-Dan which contains 19 powdered crude drug ingredients.

  • PDF

KNOCKDOWN OF IGF-1R BY ANTISENSE OLIGODEOXYNUCLEOTIDE AUGUMENTS THE SENSITIVITY OF BLADDER CANCER CELLS TO MMC

  • Wu, Shu-Fang;Sun, Hong-Zhi;Tu, Zeng-Hong
    • 한국독성학회:학술대회논문집
    • /
    • 한국독성학회 2001년도 International Symposium on Dietary and Medicinal Antimutgens and Anticarcinogens
    • /
    • pp.203-204
    • /
    • 2001
  • Background and Aim: Transitional cell carcinoma (TCC) of the bladder represents the fifth most prevalent malignancy in Western population, with peak incidence found in males of the 50- to 70-year-old age group. A major problem in the management of bladder cancer is the low sensitivity of a large proportion (approximately 40%) among bladder tumors to chemotherapy and the high risk for recurrence of bladder tumors after transurethral resection.(omitted)

  • PDF